Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Trends Cardiovasc Med ; 26(2): 182-99, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26141854

RESUMO

Atrial fibrillation (AF) is the most common arrhythmia in the elderly population and it is associated with a four-fold to five-fold increased risk of thromboembolic events. It was not until the mid-1950s that the left atrial appendage (LAA) was identified as the main location of thrombus formation, particularly in patients with non-valvular AF. In this review, we explain at some extent its embryology, anatomy and physiology, and as well as the clinical and pre-clinical trials published to date testing the safety and efficacy of most LAA closure devices. Among those devices, the most studied include the PLAATO system (ev3 Endovascular, Plymouth, MN), the Amplatzer cardiac plug (St Jude, Golden Valley, MN; St. Jude Medical, Minneapolis, MN), the WATCHMAN device (Boston Scientific, Plymouth, MN; Atritech Inc., Plymouth, MN), and the LARIAT device (SentreHEART, Palo Alto, CA). Similarly, newer LAA closure devices currently under investigation such as the Transcatheter Patch (Custom Medical Devices, Athens, Greece), AEGIS, and the Coherex WaveCrest (Salt Lake City, UT) will also be discussed. Future perspectives and the need for well-designed prospective studies between devices and new oral anticoagulant drugs are also proposed.


Assuntos
Anticoagulantes , Apêndice Atrial , Fibrilação Atrial/terapia , Cateterismo Cardíaco , Dispositivos de Fixação Cirúrgica/classificação , Trombose/prevenção & controle , Anticoagulantes/classificação , Anticoagulantes/farmacologia , Apêndice Atrial/embriologia , Apêndice Atrial/patologia , Apêndice Atrial/fisiopatologia , Apêndice Atrial/cirurgia , Fibrilação Atrial/complicações , Fibrilação Atrial/patologia , Fibrilação Atrial/fisiopatologia , Cateterismo Cardíaco/instrumentação , Cateterismo Cardíaco/métodos , Átrios do Coração , Humanos , Trombose/etiologia , Trombose/patologia , Trombose/fisiopatologia
3.
Arch. esp. urol. (Ed. impr.) ; 62(1): 34-41, ene.-feb. 2009. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-59999

RESUMO

OBJETIVO: Comparar la eficacia y morbilidad a largo plazo de pacientes con incontinencia urinaria de esfuerzo a las que se realizó uretro-cervico-suspensión tipo Burch versus el procedimiento de Burch más uraco-cistopexia.MÉTODOS: Se realizó un análisis de cohorte retrospectivo, longitudinal, comparativo y observacional. De enero de 1994 a marzo 2005 se incluyeron 129 pacientes con incontinencia urinaria de esfuerzo (IUE) o incontinencia urinaria mixta (IUM). Cincuenta y cuatro pacientes fueron sometidas a procedimiento de Burch (grupo B) y 75 pacientes a procedimiento de Burch asociado a uraco-cistopexia (grupo BU). La severidad de la incontinencia fue valorada mediante el número de apósitos utilizados durante 24 hrs. La cura se consideró cuando el paciente no requirió ningún dispositivo para la pérdida urinaria; la mejoría como una disminución a una toalla al día y fracaso el uso de más de 1 apósito en 24 horas. En la IUM, el componente de incontinencia urinaria de urgencia (IUU) se evaluó por separado(AU)


RESULTADOS: Se evaluaron 47 pacientes del grupo B y 67 pacientes del grupo BU; a los 12 meses de seguimiento observando una tasa cura/mejoría de la IUE del 74.4% (29/6) y 97% (58/7) respectivamente, p=0.001 y a los 24 meses de seguimiento 35 pacientes del grupo B y 42 pacientes del grupo BU observando una tasa del 65.7% (22/3) y 97.6% (37/4) respectivamente, p=0.014. La IUM basal se presentó en 53.7% de pacientes del grupo B y en 58.6% pacientes del grupo BU. Se analizó en forma aislada la parte de IUU de estas pacientes; a los 12 meses 53.1% de pacientes del grupo B y 19.4% del grupo BU presentaban IUU, p=0.000 y a los 24 meses 50% de pacientes del grupo B y 26.19% del grupo BU presentaban IUU, p=0.029. La IUU de novo se presentó en 19.14% de pacientes de grupo B y en el grupo BU 5.97%, p=.0000 y a los 24 meses en el grupo B 17.64% de pacientes y en el grupo BU 13.95% p=0.005. Las complicaciones relacionadas a la uraco-cistopexia se presentaron en el trans-operatorio y fue apertura vesical en 3 de los primeros casos que se resolvieron con cistorrafia en dos planos y sonda vesical por espacio de 7 días.CONCLUSIONES: El procedimiento de Burch asociado a la uraco-cistopexia tuvo mayor eficacia en la resolución a largo plazo de la IUE y del componente de IUU que el procedimiento de Burch aislado. La fijación quirúrgica del uraco a la aponeurosis de los rectos anteriores del abdomen mantiene firme la vejiga, lo que probablemente disminuye su desplazamiento durante los esfuerzos, evitando así la tensión en las fijaciones uretro-cervicales, elevando la eficacia del procedimiento de Burch(AU)


OBJECTIVES: To compare long term efficacy and morbidity in patients with stress urinary incontinence treated using Burch’s colpopexy versus Burch’s colpopexy plus urachus-cystopexy.METHODS: Retrospective, longitudinal comparative, observational study in 129 patients with stress urinary incontinence (SUI) or mixed urinary incontinence (MUI). Fifty four patients underwent Burch’s colpopexy (group B) and 75 patients underwent Burch’s colpopexy and urachus-cystopexy (group B U). These patients completed inclusion criteria from January 1994 to March 2005.The severity of SUI was evaluated by means of the number of pads used in 24 hours. Cure was defined as patients not using any pad for urinary leakage; improvement, when the number of pads used decreased to one pad a day; and failure when the patients used more than 1 pad in 24 hours. In MUI the urge urinary incontinence (UUI) component was evaluated separately.RESULTS: After 12 months of follow-up, 47 patients of group B and 67 patients of group BU were evaluated analyzing cure/improvement. Either one were observed in 74.4% (29/6) and 97% (58/7) respectively (p= 0.001). At 24 months follow up, in 35 patients of group B and 42 of group BU, a rate of 65.7% (22/3) and 97.6% (37/4) was observed respectively (p=0.014). MUI was present in 53.7% of group B and 58.6% patients of group BU. An independent analysis was made on urge urinary incontinence (UUI) in these patients at 12 months; 53.1 % of group B and 19.4 % of group BU had UUI (p= 0.000). At 24 months, 50% of patients of group B and 26.19% of group BU had UUI (p= 0.029). De novo UUI was present in 19.4% of group B and 5.97% of group BU (p= 0.000) at12 months follow-up, and in 17.64% of patients of group B and 13.95% of group BU (p= 0.005) at 24 months. Complications related to urachus-cystopexy presented trans-operatively: vesical injury in 3 of the initial cases, solved with bladder closure in two layers and vesical catheter for 7 days approximately(AU)


CONCLUSIONS: Burch’s procedure in addition to urachus-cystopexy was better for the treatment of SUI and UUI than Burch’s procedure alone in a long term clinical follow-up. Surgical fixation of the urachus to the anterior abdominal wall provides extra support to the bladder and probably reduces its displacement during strength, avoiding tension of urethral and bladder neck fixations and increasing the efficacy of Burch’s procedure(AU)


Assuntos
Humanos , Masculino , Feminino , Úraco/cirurgia , Procedimentos Cirúrgicos Urológicos/métodos , Procedimentos Cirúrgicos Urológicos/tendências , Cistocele/cirurgia , Incontinência Urinária por Estresse/cirurgia , Urodinâmica/fisiologia , Dispositivos de Fixação Cirúrgica/tendências , Procedimentos Cirúrgicos Urológicos/instrumentação , Morbidade , Estudos Retrospectivos , Estudos Longitudinais , Sinais e Sintomas , Dispositivos de Fixação Cirúrgica/classificação , Dispositivos de Fixação Cirúrgica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...